A comparison of cholinesterase inhibitors in the treatment of quinuclidinyl benzilate-induced behavioural deficit in rats performing the multiple T-maze

2014 ◽  
Vol 12 (4) ◽  
pp. 211-217 ◽  
Author(s):  
Jan Misik ◽  
Jiri Kassa
Keyword(s):  
Cholinesterase Inhibitors ◽  
Quinuclidinyl Benzilate

Assessing Cholinesterase Inhibitors

2007 ◽  
Vol 40 (18) ◽  
pp. 8-9
Author(s):  
THOMAS FINUCANE
Keyword(s):  
Cholinesterase Inhibitors

Dementia with Lewy bodies

2018 ◽  
pp. 11-21
Author(s):  
O. S. Levin ◽  
E. E. Vasenina ◽  
A. Sh. Chimagomedova ◽  
N. G. Dudchenko
Keyword(s):  
Parkinson’S Disease ◽  
Dementia With Lewy Bodies ◽  
Cholinesterase Inhibitors ◽  
Lewy Bodies ◽  
Diagnosis And Treatment ◽  
Modern Concept ◽  
Historical Aspect ◽  
Neurodegenerative Process ◽  
Icd 10

Te lecture presents modern concept of the symptoms, diagnosis and treatment of dementia with Lewy bodies (DLB), which accounts for about 10% of cases of dementia. Te nosological status of DLB and the problem of ratio of DLB and Parkinson’s disease which, apparently, represent two phenotypic variants of one neurodegenerative process («diseases with Lewy bodies») are considered in historical aspect. Approaches to the diagnosis and coding of DLB in accordance with ICD-10 are proposed. Te role of cholinesterase inhibitors, antipsychotics, levodopa, rasagiline and other drugs in the treatment of patients with DLB is аnalyzed.

Rationale for the Development of Cholinesterase Inhibitors as Anti- Alzheimer Agents

2004 ◽  
Vol 10 (25) ◽  
pp. 3111-3119 ◽  
Author(s):  
D. Lahiri ◽  
J. Rogers ◽  
N. Greig ◽  
K. Sambamurti
Keyword(s):  
Cholinesterase Inhibitors

Recent Knowledge on Medicinal Plants as Source of Cholinesterase Inhibitors for the Treatment of Dementia

2016 ◽  
Vol 16 (8) ◽  
pp. 605-618 ◽  
Author(s):  
Rosa Tundis ◽  
Marco Bonesi ◽  
Francesco Menichini ◽  
Monica R. Loizzo
Keyword(s):  
Medicinal Plants ◽  
Cholinesterase Inhibitors
Sign in / Sign up

Export Citation Format

Share Document